
### [MONDO:0015882](http://purl.obolibrary.org/obo/MONDO_0015882)
**Label:** rare tumor of pancreas

**Subclasses:** [MONDO:0019955](http://purl.obolibrary.org/obo/MONDO_0019955) (GRFoma), [MONDO:0018525](http://purl.obolibrary.org/obo/MONDO_0018525) (solid pseudopapillary carcinoma of pancreas), [MONDO:0018526](http://purl.obolibrary.org/obo/MONDO_0018526) (serous cystadenocarcinoma of pancreas), [MONDO:0018523](http://purl.obolibrary.org/obo/MONDO_0018523) (mucinous cystadenocarcinoma of pancreas), [MONDO:0016314](http://purl.obolibrary.org/obo/MONDO_0016314) (rare carcinoma of pancreas), [MONDO:0019954](http://purl.obolibrary.org/obo/MONDO_0019954) (pancreatic neuroendocrine tumor), [MONDO:0019668](http://purl.obolibrary.org/obo/MONDO_0019668) (adenoma of pancreas), [MONDO:0018524](http://purl.obolibrary.org/obo/MONDO_0018524) (intraductal papillary mucinous carcinoma of pancreas), [MONDO:0019610](http://purl.obolibrary.org/obo/MONDO_0019610) (Zollinger-Ellison syndrome), [MONDO:0018521](http://purl.obolibrary.org/obo/MONDO_0018521) (squamous cell carcinoma of pancreas), [MONDO:0018522](http://purl.obolibrary.org/obo/MONDO_0018522) (acinar cell carcinoma of pancreas), [MONDO:0019960](http://purl.obolibrary.org/obo/MONDO_0019960) (VIPoma), [MONDO:0018520](http://purl.obolibrary.org/obo/MONDO_0018520) (rare epithelial tumor of pancreas), [MONDO:0019035](http://purl.obolibrary.org/obo/MONDO_0019035) (pancreatoblastoma), [MONDO:0018582](http://purl.obolibrary.org/obo/MONDO_0018582) (GCGR-related hyperglucagonemia), [MONDO:0006976](http://purl.obolibrary.org/obo/MONDO_0006976) (somatostatinoma), [MONDO:0005048](http://purl.obolibrary.org/obo/MONDO_0005048) (insulinoma (disease)), [MONDO:0019959](http://purl.obolibrary.org/obo/MONDO_0019959) (glucagonoma), [MONDO:0019957](http://purl.obolibrary.org/obo/MONDO_0019957) (PPoma), [MONDO:0018527](http://purl.obolibrary.org/obo/MONDO_0018527) (osteoclastic giant cell tumor of pancreas), 

**Corr. equiv. classes:** [Orphanet:97283](http://www.orpha.net/ORDO/Orphanet_97283), [Orphanet:97261](http://www.orpha.net/ORDO/Orphanet_97261), [Orphanet:424046](http://www.orpha.net/ORDO/Orphanet_424046), [Orphanet:97282](http://www.orpha.net/ORDO/Orphanet_97282), [Orphanet:424058](http://www.orpha.net/ORDO/Orphanet_424058), [Orphanet:97280](http://www.orpha.net/ORDO/Orphanet_97280), [Orphanet:424039](http://www.orpha.net/ORDO/Orphanet_424039), [Orphanet:97253](http://www.orpha.net/ORDO/Orphanet_97253), [Orphanet:93292](http://www.orpha.net/ORDO/Orphanet_93292), [Orphanet:438274](http://www.orpha.net/ORDO/Orphanet_438274), [Orphanet:217074](http://www.orpha.net/ORDO/Orphanet_217074), [Orphanet:424080](http://www.orpha.net/ORDO/Orphanet_424080), [Orphanet:97279](http://www.orpha.net/ORDO/Orphanet_97279), [Orphanet:913](http://www.orpha.net/ORDO/Orphanet_913), [Orphanet:97278](http://www.orpha.net/ORDO/Orphanet_97278), [Orphanet:424073](http://www.orpha.net/ORDO/Orphanet_424073), [Orphanet:424053](http://www.orpha.net/ORDO/Orphanet_424053), [Orphanet:424065](http://www.orpha.net/ORDO/Orphanet_424065), [Orphanet:424033](http://www.orpha.net/ORDO/Orphanet_424033), [Orphanet:677](http://www.orpha.net/ORDO/Orphanet_677), 

**Class expressions from DL-Learner:**

- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0001824](http://purl.obolibrary.org/obo/HP_0001824) (Weight loss) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0100733](http://purl.obolibrary.org/obo/HP_0100733) (Neoplasm of the parathyroid gland) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0100641](http://purl.obolibrary.org/obo/HP_0100641) (Neoplasm of the adrenal cortex) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0100631](http://purl.obolibrary.org/obo/HP_0100631) (Neoplasm of the adrenal gland) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0040277](http://purl.obolibrary.org/obo/HP_0040277) (Neoplasm of the pituitary gland) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0040077](http://purl.obolibrary.org/obo/HP_0040077) (Abnormal concentration of calcium in blood) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0030338](http://purl.obolibrary.org/obo/HP_0030338) (Abnormal circulating gonadotropin level) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 62.50%
- [HP:0001031](http://purl.obolibrary.org/obo/HP_0001031) (Subcutaneous lipoma) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract) 62.50%


